Filed in archive
Treatment
by Gloria Gamat on May 10, 2007

A product of Schwarz Bioscience (U.S. subsidiary of Schwarz Pharma AG), Neupro works by delivering the drug rotigotine (a dopamine agonist) continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours.
[A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine.]
Neupro is the first transdermal patch approved for the treatment of symptoms of Parkinson's disease - belongs to a group of conditions called motor system disorders that is a result of the loss of dopamine-producing brain cells.
Read the full report from Schwarz Pharma and FDA.
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/68463
Mr Wong
Vote for Neupro® (rotigotine transdermal system): First FDA-Approved Parkinson's Disease Patch:
|
Rating: 6.00 out of 2 vote(s) cast.
|
Response from:
declan
(12/18/07 6:53pm)
Since starting the patch six weeks ago I have had high blood pressure for the firstime and had almost constant nose bleeds and evntually hospitalised It may not be the patch but I wonder
Response from:
tavel
(01/14/08 12:37am)
has anybody experience wit 12-14 mg daily + ledopad (cienemet )
Response from:
Johnson Chen
(01/16/08 2:51pm)
HealthLat is inviting patients who take Neupro, and physicians who prescribe it to report their experiences with the new drug. Your experiences will help patients needed and make money for you.
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
You are also welcome to check how Neupro has been used by other patients. It is free.
For details, please visit: http://www.healthlat.com
Response from:
Trusted.MD Network
With no cure and still of unknown cause - Crohn's disease - is a chronic, inflammatory bowel disease that affects more than 1 million men and women worldwide.
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









